Credit Agricole’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,400
Closed -$234K 696
2021
Q2
$234K Hold
3,400
﹤0.01% 342
2021
Q1
$262K Buy
+3,400
New +$313K 0.01% 314

Other funds holding LKFT

Credit Agricole's LKFT Position: Q3 2021 in Review

Credit Agricole sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 3,400 shares — an estimated $234K sold.

Credit Agricole first reported a position in LKFT in Q1 2021 and held it in 2 quarters. The position peaked at $262K in Q1 2021. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • Credit Agricole reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 3,400 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $234K.
  • Credit Agricole first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Credit Agricole's Lakefront Biotherapeutics American Depositary Shares position peaked at $262K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.